Rivaroxaban (BAY 59-7939) is an oral anticoagulant it is marketed as Xarelto. It is the first available orally active direct factor Xa inhibitor.
In those with non-valvular atrial fibrillation it is used in preventing nonhemorrhagic strokes and embolic events. Rivaroxaban is associated with lower rates of serious and fatal bleeding events than warfarin, though rivaroxaban is associated with higher rates of bleeding in the gastrointestinal tract.
Adverse effects
As with any anticoagulant the most serious adverse effect is bleeding, including severe internal bleeding. There is currently no antidote for rivaroxaban (unlike warfarin, the action of which can be reversed with vitamin K or prothrombin complex concentrate), meaning that serious bleeding may be difficult to manage. A possible antidote (andexanet alfa) is being investigated. Post-marketing assessments showed signs of liver toxicity associated with rivaroxaban, although studies are required to adequately quantify the risk.
On Dec, 26, 2016 65,776 people reported to have side effects when taking Xarelto.
Among them, 94 people (0.14%) have Hallucination
Time on Xarelto when people have Hallucination :
| |
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
| Hallucination |
96.55% |
3.45% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Gender of people who have Hallucination when taking Xarelto :
| |
Female |
Male |
| Hallucination |
69.57% |
30.43% |
Age of people who have Hallucination when taking Xarelto :
| |
0-1 |
2-9 |
10-19 |
20-29 |
30-39 |
40-49 |
50-59 |
60+ |
| Hallucination |
0.00% |
0.00% |
0.00% |
0.00% |
3.03% |
0.00% |
0.00% |
96.97% |
Severity of Hallucination when taking Xarelto :
| |
least |
moderate |
severe |
most severe |
| Hallucination |
0.00% |
100.00% |
0.00% |
0.00% |
How people recovered from Hallucination :
| |
while on the drug |
after off the drug |
not yet |
| Hallucination |
0.00% |
0.00% |
100.00% |
On Feb, 3, 2016: 4,701 people reported to have side effects when taking Xarelto. Among them, 107 people (2.28%) have Death.
Time on Xarelto when people have Death :
| |
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
| Death |
100.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Gender of people who have Death when taking Xarelto :
| |
Female |
Male |
| Death |
55.33% |
44.67% |
Age of people who have Death when taking Xarelto :
| |
0-1 |
2-9 |
10-19 |
20-29 |
30-39 |
40-49 |
50-59 |
60+ |
| Death |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
10.00% |
2.50% |
87.50% |
Top conditions involved for these people :
- Atrial fibrillation (54 people, 50.47%)
- Cerebrovascular accident prophylaxis (33 people, 30.84%)
- Ill-defined disorder (14 people, 13.08%)
- Knee arthroplasty (14 people, 13.08%)
- Dyspepsia (12 people, 11.21%)
